| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.32▲ | 9.29▲ | 9.26▲ | 9.23▲ | 9.30▲ |
| MA10 | 9.31▲ | 9.23▲ | 9.22▲ | 9.18▲ | 9.79▼ |
| MA20 | 9.26▲ | 9.19▲ | 9.17▲ | 9.23▲ | 9.67▼ |
| MA50 | 9.21▲ | 9.17▲ | 9.18▲ | 9.75▼ | 9.74▼ |
| MA100 | 9.14▲ | 9.17▲ | 9.22▲ | 9.61▼ | 8.51▲ |
| MA200 | 9.16▲ | 9.21▲ | 9.63▼ | 10.02▼ | 7.64▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | 0.021▲ | 0.023▲ | 0.026▲ | -0.088▼ |
| RSI | 61.732▲ | 63.578▲ | 59.563▲ | 47.163▼ | 45.477▼ |
| STOCH | 85.804▲ | 87.209▲ | 83.230▲ | 55.624 | 36.539 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -33.333 | -68.354 |
| CCI | 90.292 | 133.013▲ | 135.552▲ | 32.325 | -116.552▼ |
|
Thursday, May 01, 2025 01:07 PM
Biotech company Amgen (NASDAQ:AMGN) announced in Q1 CY2025, with sales up 9.4% year on year to $8.15 billion. The company expects the full year’s revenue to be around $35 billion, close to analysts’ ...
|
|
Thursday, May 01, 2025 05:32 AM
TransCode Therapeutics, Inc. (NASDAQ:RNAZ) announced further progress on Thursday in its Phase 1a clinical trial of TTX-MC138 in patients with metastatic cancer. To date, 13 patients have received at ...
|
|
Thursday, May 01, 2025 04:00 AM
Enrollment complete in the 12 mg dose cohort (n=16) of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD); initiated the 20 mg dose cohort ― ― On track to provide clinical data from ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/05/25 | 9.175 | 9.33 | 9.15 | 9.33 | 24,844 |
| 01/05/25 | 9.20 | 9.32 | 9.07 | 9.16 | 87,000 |
| 30/04/25 | 9.18 | 9.25 | 8.87 | 9.12 | 127,200 |
| 29/04/25 | 9.15 | 9.41 | 9.15 | 9.30 | 67,303 |
| 28/04/25 | 9.18 | 9.30 | 9.04 | 9.22 | 100,300 |
| 25/04/25 | 9.17 | 9.23 | 8.9996 | 9.19 | 77,578 |
| 24/04/25 | 9.15 | 9.31 | 9.14 | 9.28 | 105,100 |
| 23/04/25 | 9.33 | 9.49 | 9.13 | 9.19 | 123,225 |
| 22/04/25 | 9.06 | 9.16 | 8.90 | 9.06 | 96,800 |
| 21/04/25 | 9.23 | 9.24 | 8.85 | 8.94 | 136,100 |
|
|
||||
|
|
||||
|
|